Genetic variation of staphylococcal LukAB toxin determines receptor tropism

葡萄球菌 LukAB 毒素的遗传变异决定了受体嗜性

阅读:2
作者:Sofya S Perelman # ,David B A James # ,Kristina M Boguslawski # ,Chase W Nelson ,Juliana K Ilmain ,Erin E Zwack ,Rachel A Prescott ,Adil Mohamed ,Kayan Tam ,Rita Chan ,Apurva Narechania ,Miranda B Pawline ,Nikollaq Vozhilla ,Ahmed M Moustafa ,Sang Y Kim ,Meike Dittmann ,Damian C Ekiert ,Gira Bhabha ,Bo Shopsin ,Paul J Planet ,Sergei B Koralov ,Victor J Torres

Abstract

Staphylococcus aureus has evolved into diverse lineages, known as clonal complexes (CCs), which exhibit differences in the coding sequences of core virulence factors. Whether these alterations affect functionality is poorly understood. Here, we studied the highly polymorphic pore-forming toxin LukAB. We discovered that the LukAB toxin variants produced by S. aureus CC30 and CC45 kill human phagocytes regardless of whether CD11b, the previously established LukAB receptor, is present, and instead target the human hydrogen voltage-gated channel 1 (HVCN1). Biochemical studies identified the domain within human HVCN1 that drives LukAB species specificity, enabling the generation of humanized HVCN1 mice with enhanced susceptibility to CC30 LukAB and to bloodstream infection caused by CC30 S. aureus strains. Together, this work advances our understanding of an important S. aureus toxin and underscores the importance of considering genetic variation in characterizing virulence factors and understanding the tug of war between pathogens and the host.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。